Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of new Alzheimer's disease drug candidates using donepezil as a key model
Kholoud I. Eissa, Mona M. Kamel, Lamia W. Mohamed, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 1
Closed Access | Times Cited: 10

Showing 10 citing articles:

Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer’s Disease: Superior Efficacy of Extracellular Vesicles Over Polymeric Nanoparticles
Rummenigge Oliveira Silva, Hermine Counil, Jean‐Michel Rabanel, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1077-1096
Open Access | Times Cited: 11
Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease
Kholoud I. Eissa, Mona M. Kamel, Lamia W. Mohamed, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 937-961
Closed Access | Times Cited: 16
Transcranial alternating current stimulation combined with sound stimulation improves cognitive function in patients with Alzheimer’s disease: Study protocol for a randomized controlled trial
Yang Liu, Shuzhen Liu, Can Tang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 13
Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease
Violina T. Angelova, B. Georgiev, Tania Pencheva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1194-1194
Open Access | Times Cited: 12
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 3
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 3
Torreya grandis oil attenuates cognitive impairment in scopolamine-induced mice
Jiachen Ma, Tian Yuan, Yu-Qi Gao, et al.
Food & Function (2023) Vol. 14, Iss. 23, pp. 10520-10534
Closed Access | Times Cited: 6
Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease
J. Domingo Sánchez, Andrés R. Alcántara, Juan F. González, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1413-1428
Closed Access | Times Cited: 5
An Exquisite Design Process and Impacting Synthesis of 2-methyl Nicotinamide Derivatives and their Anti-bacterial Activity Closet to Fab I Inhibitors
S. Raghunadh Acharyulu, N. Srinivasu, Sivaranjani Jampala, et al.
Oriental Journal Of Chemistry (2024) Vol. 40, Iss. 5, pp. 1250-1260
Open Access
Synthesis, biological evaluation, and computational studies of N -benzyl pyridinium–curcumin derivatives as potent AChE inhibitors with antioxidant activity
Nafisah Al‐Rifai, Nemeh M. Al-Khalileh, Jalal A. Zahra, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access
Page 1

Scroll to top